Brief: Astellas Pharma, Yaskawa Electric: Agree To Establish Joint Venture Focused On Cell Therapy Manufacturing
06/03/2025 04:06
March 6 (Reuters) - Astellas Pharma Inc 4503.T: ASTELLAS PHARMA, YASKAWA ELECTRIC: AGREE TO ESTABLISH JOINT VENTURE FOCUSED ON CELL THERAPY MANUFACTURING Source text: https://www.astellas.com/en/news/29761 Further company coverage: 4503.T (Reporting by Kantaro Komiya) ((Kantaro.Komiya@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn